Hongyuan Cao to Humans
This is a "connection" page, showing publications Hongyuan Cao has written about Humans.
Connection Strength
0.056
-
Medical records-based postmarketing safety evaluation of rare events with uncertain status. J Biopharm Stat. 2013; 23(1):201-12.
Score: 0.014
-
Medical records-based postmarketing safety evaluation of rare events with uncertain status. J Biopharm Stat. 2013; 23(4):744-55.
Score: 0.014
-
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clin Cancer Res. 2019 03 15; 25(6):1786-1794.
Score: 0.005
-
Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. Clin Genitourin Cancer. 2016 12; 14(6):511-517.
Score: 0.004
-
Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer. Anticancer Drugs. 2015 Mar; 26(3):343-9.
Score: 0.004
-
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant. Leuk Lymphoma. 2014 Dec; 55(12):2866-73.
Score: 0.004
-
Urinary and dietary analysis of 18,470 bangladeshis reveal a correlation of rice consumption with arsenic exposure and toxicity. PLoS One. 2013; 8(11):e80691.
Score: 0.004
-
Racial parities in outcomes after radiotherapy for head and neck cancer. Cancer. 2014 Jan 15; 120(2):244-52.
Score: 0.004
-
A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery. 2013 Dec; 154(6):1436-46; discussion 1446-7.
Score: 0.004